A recent study confirmed our results and suggested that inhibition of GSK3β decreased p-mTOR levels and downstream molecules, which were related to cell survival and growth in HCC cells and inhibited tumour growth in vivo [20]. Here, MTOR is linked to hepatocellular carcinoma.